InvestorsHub Logo
Followers 13
Posts 1547
Boards Moderated 0
Alias Born 06/14/2018

Re: hanscott post# 28312

Saturday, 08/24/2019 11:06:50 AM

Saturday, August 24, 2019 11:06:50 AM

Post# of 34626
Howdy hanscott. I did file a complaint with the SEC within a week of AACR event.
I agree with "no need to single out Fidelity".
I'm with TD Ameritrade and they were doing the same exact thing.
I believe some peoples objections were the 60% to 80% interest rate Fidelity and other brokers were getting in return to lend the shares to short. I understand that that is normal business, but to some, it tends to make them look complicit in the crash.

CHM_760 said "I'm guessing that Susquehanna and Citadel are heavily involved in the recent shorting. These two Hedge funds are well known for going after micro-cap biotech stocks. Eventually they'll move on to some other victim."

The (what I think is) reasonable scenario has been the Hedge Funds.
In my mind, all it takes is a few connected friends who know what
"did you happen to notice" means.
Susquehanna shorts, then calls Joe from Citadel and says, did you happen to notice MRKR going down today.
After Joe shorts, he calls Fred and says, did you happen to notice MRKR going down today.
And all of a sudden, you have a Billion dollars in capital betting against MRKR because they all know "did you happen to notice" (or whatever the cue phase is) means let's all get together and pound this thing down and make a ton of money doing it.

Now Hey, I could be wrong, all I know is, from all my many years of small cap bio buying, and reactions to good phase 1 data, with MRKR's pipeline, something was/went wrong.

But in the end, no matter what the reasons, we are all on the same team, standing right along the patients and clinicians, rooting for the same outcome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News